x
ServiziMenu principaleHome
You are here: Home > What we do > Past events > 2010 > 4th Familial Cancer Conference
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

4th Familial Cancer Conference

Not eligible for ESCO credits

07.06.2010  -  08.06.2010

Madrid, Spain

CONFERENCE

Medical / clinical oncology

Description

Chair: J. Benítez, ES - H. Vasen, NL

 

The 4th Familial
Cancer
Conference is an
ESO-CNIO joint event

 

General information

ORGANISING SECRETARIAT
Ana Sofia Contreiras Cordeiro/Danielle Rouse
Centro Nacional de Investigaciones Oncológicas (CNIO) - Scientific Events
Melchor Fernández Almagro, 3
E-28029 Madrid - Spain
Tel: +34 91 224 6900
Fax: +34 91 224 6980
Email:
meetings@cnio.es

ESO SECRETARIAT
Daniela Mengato
European School of Oncology
Via del Bollo 4
20123 Milan - Italy
Tel: +39 02 8546 4523
Fax: +39 02 8546 4545
Email:
dmengato@eso.net

CONFERENCE VENUE
Centro Nacional de InvestigacionesOncológicas (CNIO)
Melchor Fernández Almagro, 3
E-28029 Madrid - Spain

OFFICIAL LANGUAGE
The official language of the conference will be English. No simultaneous translation will be provided.

CERTIFICATES
All participants will be issued with a certificate of attendance at the close of the conference.
The meeting has been appraised and approved by the Accreditation Council of Oncology in Europe (ACOE) acknowledging the quality of the scientific programme and its educational value. The event is accredited with 12 European CME credits

BADGE
The badge is the only official evidence of registration and should be worn at all times during the conference. Loss of badge means loss of registration.

INSURANCE
The organisers bear no responsibility for untoward events in connection with, before, during and after the conference. Participants are strongly advised to take out their own personal and travel insurance coverage.

IMPORTANT DEADLINES
15/05/2010: poster abstracts deadline
15/05/2010: registration deadline (after this date, registration will only be available on-site)
15/05/2010: cancellation deadline
24/05/2010: replacement deadline

Faculty list

FACULTY

L. Aaltonen, University of Helsinki, FI
A. Antoniou, University of Cambridge, UK
J. Benítez, Centro Nacional de Investigaciones Oncológicas, Madrid, ES
B. Bressac de Paillerets, Institute Gustave Roussy, Villejuif, FR
A. Castells, Hospital Clínic, Barcelona, ES
D. Goldgar, University of Utah, Salt Lake City, US
C. Guerra, Centro Nacional de Investigaciones Oncológicas, Madrid, ES
C. Houdayer, Institut Curie, Paris, FR
Z. Kote-Jarai, The Institute of Cancer Research, Sutton, UK
F. Lalloo, St Mary’s Hospital, Manchester, UK
P. Lapunzina, Hospital La Paz, Madrid, ES
C. Lázaro, Institut Català d'Oncología, Barcelona, ES
J. Lubinski, Pomeranian Academy of Medicine, Szczecin, PL
E.R. Maher, University of Birmingham, UK
A. Osorio, Centro Nacional de Investigaciones Oncológicas, Madrid, ES
J. Palacios, Hospitales Universitarios Virgendel Rocio, Sevilla, ES
P. Radice, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, IT
M. Robledo, Centro Nacional de Investigaciones Oncológicas, Madrid, ES
S. Romeo, University of Las Palmas, Las Palmas de Gran Canaria, ES
S. Shanley, Royal Marsden Hospital, London, UK
D. Stoppa-Lyonet, Institut Curie, Paris, FR
J. Surralles, Universitat Autónoma de Barcelona, ES
S. Thorlacius, University of Turin, IT
I. Tomlinson, University of Oxford, UK
M. Urioste, Centro Nacional de Investigaciones Oncológicas, Madrid, ES
H. Vasen, Leiden University Medical Centre,Leiden, NL

Programme

7 June

 

GENERAL CONCEPTS IN FAMILIAL CANCER
Chair: J. Benítez, ES

 9:00

Welcome
J. Benítez, ES

 9:10

Genetic predisposition. Hereditary cancer syndromes
J. Benítez, ES

 9:30

Familial cancer epidemiology
J. Lubinski, PL

9:50Genetic factors and cancer predisposition
A. Antoniou, UK
 10:10

Evaluation of unclassified variants
D. Goldgar, US

10:30

Group picture and coffee break. Poster discussion
 11:00Genetic  counseling in familial cancer
D. Stoppa-Lyonet, FR
 11:20Legal and ethical issues of genetic testing
S. Romeo, ES
 11:40Round table
 HEREDITARY BREAST AND OVARIAN CANCER
Chair: J. Lubinski, PL
 12:00The family of breast cancer genes   
A. Osorio, ES
 12:20The pathology of BRCA1 and BRCA2 breast cancer
J. Palacios, ES
 12:40Selection criteria and management choices in families at high genetic risk for breast/ovarian cancer
F. Lalloo, UK

 13:00

Early detection and new treatments for women at high risk 
S. Shanley, UK
 13:20Round table 
 13:40Lunch break
 15:15Oral presentation from selected posters
Chair: P. Radice, IT
 16:30Coffee break and poster discussion
 17:00Clinical cases
Chair: H. Vasen, NL
 

 

 

8 June

 

COLORECTAL CANCER
Chair: D. Stoppa-Lyonet, FR

 9:00

Germinal genetic and epigenetic alterations in HNPCC
P. Radice, IT

 9:20

The genetic bases of FAP syndrome
M. Urioste, ES

 9:40Management of patients with FAP syndrome
A. Castells, ES
 10:00

Other CRC genes
L. Aaltonen, FI

10:20Round table

10:40

Coffee break and poster discussion

 

OTHER INHERITED CANCER SYNDROMES
Chair: L. Altonen, FI

11:10

New advances in Multiple Endocrine Neoplasia type 2
M. Robledo, ES

 11:30The genetic portrait of familial melanoma
B. Bressac de Paillerets, FR
 11:50Genetic complexity of neurofibromatosis 1 (NF1)
C. Lázaro, ES
 12:10Clinical features and molecular genetics of VHL syndrome
E.R. Maher, UK
 12:30Genetic and management of hereditary pancreatic syndromes
H. Vasen, NL 
 12:50Round table 
 13:10Lunch break
 CANCER IN CHILDHOOD
Chair: F. Lalloo, UK
 14:45The Fanconi Anemia Syndrome
J. Surralles, ES
 15:05The overgrowth syndromes and cancer predisposition
P. Lapunzina, ES 
 15:25Familial retinoblastoma (Rb). Genotype-phenotype correlations
C. Houdayer, FR
 15:45Genetic Syndromes of the Ras/MAPK Pathway 
C. Guerra, ES
 16:05Round table 
 16:25Coffee break and poster discussion 
 NEW STRATEGIES IN THE SEARCH FOR CANCER GENES
Chair: M. Robledo, ES 
 16:55Searching for high penetrance genes by linkage studies
I. Tomlinson, UK
 17:15High throughput sequencing: Searching for cancer genes
S. Thorlacius, IT 
 17:35GWAS and prostate cancer
Z. Kote-Jarai, UK 
 17:55Round table 

 

Abstract

APPLICATION AND ABSTRACT SUBMISSION


You may apply and submit your abstract to the organising secretariat online at:
WWW.CNIO.ES/MEETINGS

Instructions for application and abstract submission
Participants with new data relevant to the subject of the conference may submit one abstract to be considered for poster presentation. Only papers whose abstracts have been reviewed and approved by the conference coordinators will be presented.
Abstracts should be written in English and the text should not exceed 2000 characters (or 450 words), title included.
The title should appear in capital letters.
For each author, type surname first, followed by first name and initials (presenting author incapital letters).
List of affiliations after the author's list.
Indicate 3-5 keywords at the end of the text.
The full address with telephone, fax number and email of the corresponding author must be provided. The corresponding author will receive all the subsequent communication concerning this abstract. Please also indicate your approval for publication in case the abstracts are issued in a journal.
Six posters will be selected for the oral presentation.
It is the responsibility of the presenting author to ascertain whether all authors are aware of the content of the abstract before submission.


THE POSTER ABSTRACTS DEADLINE IS PASSED (15 MAY 2010)